News from polaris group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 06, 2016, 12:00 ET FLT-PET Scan Provides Early Evidence of Response to Arginine Depletion by ADI-PEG 20 in Argininosuccinate Synthetase Deficient Thoracic Tumors

 Polaris Group announced today that FLT-PET scan provided early evidence of response to arginine depletion by its lead therapeutic ADI-PEG 20...


Jun 06, 2016, 12:00 ET Polaris Group Reports Phase III Study Results of ADI-PEG 20 plus Best Supportive Care in Advanced Hepatocellular Carcinoma

 Polaris Group announced today that the phase III study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive...


Jun 03, 2016, 10:00 ET ADI-PEG 20 plus Gemcitabine and nab-Paclitaxel Shows Robust Anti-tumor Activity in Advanced Pancreatic Cancer

Polaris Group announced today results from an ongoing phase 1b study conducted at Memorial Sloan Kettering Cancer Center that tests combining...


Apr 18, 2016, 13:30 ET ADI-PEG 20 is a Potential Salvage Therapy for BRAFi Resistant Melanoma

 Polaris Group announced today that ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, is a potential salvage therapy for BRAF...


Nov 11, 2015, 13:30 ET Polaris Group's ADI-PEG 20 Shows Robust Clinical Activity in Malignant Plural Mesothelioma and NSCLC When Combined with Standard First Line Chemotherapy Regimen

Polaris Group announced today the preliminary results from an ongoing phase 1 study that tests combining its lead therapeutic ADI-PEG 20 (pegylated...


Feb 03, 2015, 13:15 ET Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus FOLFOX in Advanced Gastrointestinal Malignancies

Polaris Group announced today that the first patient has been dosed in its Phase 1 trial of ADI-PEG 20 in combination with folinic acid...


Apr 02, 2014, 17:00 ET Shaw T. Chen, M.D., Ph.D. joins Polaris

 Polaris Group announced today that Shaw T. Chen, M.D., Ph.D. has joined Polaris Pharmaceuticals, Inc. (a subsidiary of Polaris Group) as...


Jan 27, 2014, 10:30 ET Polaris Group's ADI-PEG 20 is a Radiosensitizer of Pancreatic Cancer

Polaris Group announced today that ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, acts as a radiosensitizer of pancreatic...


Dec 02, 2013, 10:30 ET Polaris Group Files New IND for ADI-PEG 20 in Leukemia

 Polaris Group announced today that it has filed an Investigational New Drug Application (IND) application with the United States Food and Drug...